GRACE SUHU: Open Payments
NPI 1477816379 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$411 in 10 payments from 6 companies in 2025. Trend: 2023 $178 · 2024 $237 · 2025 $411
Food & beverage: $312Education: $99
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $163 |
| Incyte Corporation | 1 | $99 |
| Novartis Pharmaceuticals Corporation | 3 | $82 |
| Astellas Pharma US Inc | 1 | $25 |
| Stemline Therapeutics Inc. | 1 | $25 |
| SOBI, INC | 1 | $17 |
Products named: ICLUSIG, Fabhalta, Cresemba, ELZONRIS, SCEMBLIX, NINLARO, Vonjo.
Industry payments across NY — which companies pay providers there.
